Cdex, Inc. (fka CDEX)

[capnmike]

Relax folks. CDEX will either be successful, or not be successful, based upon the ValiMed G4 product performance. I still believe the G4 will prove successful in 2013.
CDEX folk attend Health Connect Partners reverse expos, ASHP events, and they are well connected in the pharmaceutical industry. Sept, Oct, Nov, and December should be interesting.
Relax, get some popcorn, and we can all watch.

http://connect.ashp.org/MSC13/Home/

http://www.hlthcp.com/

http://connect.ashp.org/MCM13/Home/

http://s15.a2zinc.net/clients/ASHP/2013midyear/public/EventMap.aspx?ver=HTML&shMode=E&ID=158&sortMenu=103001

http://appft.uspto.gov/netahtml/PTO/search-bool.html

Inventors: POTEET; Wade M.; (Vail, AZ) ; STARZINGER; Carey W.; (Benson, AZ) ; BRUMFIELD; Jeffery K.; (Romona, CA)
May 2013
United States Patent Application 20130120741

[0006] The disclosed embodiments also provide the capability of identifying individual components of a mixture or compound having more than one substance. The disclosed embodiments also may report the constituent molecular identification and concentration.

[0012] Another application for the disclosed embodiments may include determining the potency of a drug or group of drugs over a period of time. The "decay" or potency degradation over time of the amount of a material within a combination of substances may be determined using the disclosed embodiments. The molecular analysis and determination may determine any breakdown of the target substance over time.

http://finance.yahoo.com/news/CDEX-Ships-ValiMed-G4-iw-3043086989.html

CDEX Ships ValiMed G4 Medication Validation System
Prominent Global Medical Technology Company to Use for Research and Development

[CDEX]has shipped the first ValiMed™ G4 drug validation system to a prominent US based global medical technology company. The company intends using the ValiMed G4 as a lab instrument for a research and development project to determine the shelf life of parenteral admixtures with regards to potency over time.